Figure 2. Distribution of Deteriorated Functional Assessment of Cancer Treatment/Gynecologic Oncology Group–Neurotoxicity (FACT/GOG-NTX) Items by Total Neuropathy Score, Clinical Version (TNSc) Category.
(A) Overall. (B) Patients treated with taxanes. (C) Patients treated with platinum drugs. (D) Patients treated with taxanes + platinum drugs. For all groups, the Kruskal-Wallis test p value was <0.001.
